A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 40,292 shares of AUPH stock, worth $302,995. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40,292
Holding current value
$302,995
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$4.81 - $5.78 $193,804 - $232,887
40,292 New
40,292 $230,000
Q2 2023

Aug 14, 2023

SELL
$8.96 - $11.69 $494,117 - $644,668
-55,147 Reduced 58.12%
39,733 $384,000
Q1 2023

May 15, 2023

BUY
$5.94 - $11.27 $563,587 - $1.07 Million
94,880 New
94,880 $1.04 Million

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.07B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.